[ad_1] The FDA said its unannounced visit of Juul collected documents on the e-cigarette-maker’s sales and marketing practices. Photo: Gabby Jones/Bloomberg News Updated Oct. 2, 2018 2:04 p.m. ET The Food and …
Read More »FDA Seizes Thousands of Docs in Surprise Raid on Juul
[ad_1] The Food and Drug Administration announced that it was a surprise inspection of e-cigarette maker Juul, CNBC reported. The scrutiny follows the Trump administration's request for documents in April, as part …
Read More »The FDA captures documents during a surprise inspection of electronic cigarette manufacturer Juul
[ad_1] Gabby Jones | Bloomberg | Getty Images One person smokes an e-cigarette Juul Labs on this arranged photograph taken in Brooklyn, New York. The Food and Drug Administration has seized "thousands …
Read More »Will the FDA be able to treat psilocybin in the near future?
[ad_1] Researchers at the Johns Hopkins University School of Medicine recently reviewed existing research on the safety and potential abuse of psilocybin, the active ingredient in hallucinogenic ("magic") mushrooms. In their summary, …
Read More »New FDA approved migraine prevention drug
[ad_1] A new drug used to help prevent migraines in adults has just been approved by the US Food and Drug Administration, WAFB reports. The new drug is called Emgality and is …
Read More »FDA approves another migraine medication that may not be expensive … for the moment
[ad_1] A new migraine drug is entering an already crowded market, but it could mean fewer headaches for some patients. The pharmaceutical group Eli Lilly announced Thursday that the FDA had approved …
Read More »FDA Approves Third Migraine Preventive Drug That May Be Free (VIDEO)
[ad_1] A new migraine drug is entering an already crowded market, but it could mean fewer headaches for some patients. The pharmaceutical group Eli Lilly announced Thursday that the FDA had approved …
Read More »A pediatric antiepileptic drug gets FDA approval
[ad_1] The US Food and Drug Administration (FDA) has approved the use of the perampanel antiepileptic drug (FYCOMPA) CIII as monotherapy and adjunctive therapy in pediatric patients for the treatment of partial …
Read More »Eisai Announces FDA Approval of FYCOMPA® in Pediatric Patients From the Age of 4 Years for the Treatment of Partial Seizures
[ad_1] WOODCLIFF LAKE, N.J., September 28, 2018 / PRNewswire / – Eisai Inc. announced today that the United States Food and Drug Administration (FDA) has expanded the indication of its antiepileptic drug …
Read More »FDA Approves New Antibacterial Drug To Treat Severe Pulmonary Disease By Using A New Path To Stimulate Innovation
[ad_1] The US Food and Drug Administration today approved a new drug, Arikayce (suspension of amikacin liposome inhalation), to treat a lung disease caused by a group of bacteria Mycobacterium avium complex …
Read More »